Hannah Michelle Loman

Recommended Articles

• What Does Bactrim Treat?

  BactrimBactrim is a combination of antibiotics called trimethoprim and sulfamethoxazole, which help treat different types of bacterial infections. Bactrim can be used for the treatment of urinary tract infections (UTIs), ear infections, bronchitis, shigellosis, traveler's...

• What is Mesothelioma?

  Mesothelioma is an aggressive form of cancer that affects the mesothelium, the protective tissue lining covering internal organs, like the lungs and abdomen. Cancer of mesothelium may begin in the pleural membrane, the abdominal cavity or the heart. The cancerous cells may then invade the...

• Is Mineral Makeup Effective?

  What Is Mineral Makeup?Mineral makeup has become a very popular cosmetic product, with many celebrities vouching for its effects. Adding to its popularity are the innumerable and attractive advertisements for these products. With more and more people demanding a more natural complexion and look,...

• Vitamin D Pills Can Help Reduce the Pain Caused By Menstruation

  A study conducted by Italian researchers has shown that a single dose of vitamin D may reduce the pain experienced during menstrual cycles in women, and help them to avoid taking pain killers. In this study, the researchers studied the effect of vitamin D on 40 women between the ages of 18-years-old...

• Saliva Test to Diagnose Lupus May Soon Exist

  Researchers have created a simplified technique to diagnose lupus using saliva. The initial research took place at the University of Houston, and was thanks to a $387,000 grant from the National Institutes of Health.  If successful, the saliva test could very well replace the invasive methods that...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...